Since it was founded in 1986, Centaur Animal Health business focus has been concentrated in adaptations of proven new technology -- with special emphasis in biotechnology -- converting successes from the human healthcare market to help similar problems in the animal health markets. Centaur’s first products were concentrated in the equine market, and focused on diagnostic technologies that were representative of ‘breakthrough innovations’. One such product is the Equine Infectious Anemia (EIA) diagnostic that was adapted from the human AIDS test and for which a patent was granted in 1995. Centaur, Animal Health and United Agriculture and Veterinary Products, Inc. (Unavet) were two separate Kansas City based animal health businesses that have been operational since the mid 1980’s. Both companies had been engaged in sales activity in separate but complimentary segments of the animal health market. The merging of the two existing companies in 2001 provided efficiencies and growth opportunities available that would not have been available to either company individually.